Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study observed that Iraqi women with female pattern hair loss had significantly lower serum vitamin D levels compared to healthy controls, suggesting a possible role of vitamin D in the condition's development.

This article reviews the diagnosis and treatment options for female androgenetic alopecia and female pattern hair loss but presents no new research results.

This review discusses the application of improved hair transplantation techniques for women and notes that 70% of females with androgenetic alopecia are candidates for this treatment; it reports no new clinical results.

In this study, mesotherapy containing nutritional supplements was found to increase patient satisfaction and improve the number of hair follicles more effectively than topical minoxidil in treating female pattern hair loss, though both methods showed similar overall efficacy in hair density and hair loss reduction.

This publication describes the role of the Revista Brasileira de Cirurgia Plástica in documenting and promoting advancements in plastic surgery, but does not present new research findings.

Cyproterone acetate therapy improved hair loss and reduced testosterone levels in a menopausal woman.

In this study, female patients with androgenetic alopecia reported high stress levels, but the type of hair loss treatment did not significantly affect stress alleviation.

In this study, TrichoScan characteristics, particularly hair density and terminal hair percentage in the midscalp, were found to predictively classify female pattern hair loss in a Chinese population.

Female Pattern Hair Loss affects women's quality of life, with limited treatment options and a need for more research.

This study suggests that hormonal disturbances play a role in female pattern hair loss and that trichoscopy may be a useful tool for diagnosis and differentiation from other conditions.

This study found that androgenetic alopecia significantly impairs quality of life among Nigerian patients, especially in areas like emotions, stigmatization, and self-confidence, highlighting the importance of psychosocial support.

Acne severity is not related to the type or severity of androgenetic alopecia.

This study demonstrated that engineered exosomes carrying EGF and FGF restored hair density and follicle integrity in an androgenetic alopecia mouse model by reactivating hair follicle growth factors, offering a novel therapeutic approach without immunogenic reactions or systemic toxicity.

A new reliable scale improves accuracy in measuring hair density and treatment response.

This review discusses telogen effluvium and highlights the importance of considering seasonal hair shedding fluctuations in managing hair loss and evaluating hair growth treatments, without presenting new clinical findings.

This study found that patients with trichodynia associated with androgenetic alopecia had significantly higher levels of substance P in both tissue and serum compared to healthy controls, suggesting a potential role for this neurotransmitter in the condition's pathogenesis.

This review discusses the complex diagnosis and management of telogen effluvium, noting its high prevalence, psychosocial impact, and need for quantitative diagnostic techniques, but it reports no new research findings.

The researchers reported that one-third of women with female pattern hair loss in their study had occipital region involvement, which is important for diagnosing and planning treatment, including hair restoration surgery, as the occipital region is often used as a normal reference.

This article reviews the evolution of hair restoration techniques towards using follicular units for more natural results and emphasizes the need for surgeons to understand related procedures and complications, without reporting new clinical findings.

This research found evidence of inflammatory involvement in androgenetic alopecia, with higher deposition of certain immune components in the scalp of affected patients compared to those without baldness.

This study found that patients with androgenetic alopecia had a higher prevalence of metabolic syndrome compared to healthy controls.

This study found that male hospital staff in China had a higher prevalence of androgenetic alopecia compared to the general male population, while there was no significant difference among females.

This study concluded that ALRV5XR treatment significantly increased terminal hair density in both men and women with androgenetic alopecia and telogen effluvium, with more pronounced effects in women.

This study found that the prevalence of androgenetic alopecia among adults in Ogbomoso, Nigeria, was 29.95%, with a higher incidence in men and mixed type baldness as the most common phenotype.

This study found that patients with alopecia areata had significantly higher troponin I levels compared to those with female pattern hair loss and healthy controls, suggesting an association with cardiovascular diseases.

This study reported that age and diabetes are major factors influencing trichilemmal cyst development and size, highlighting the importance of these conditions for risk assessment and surgical planning.

This study found that a novel dietary supplement, AGA-P, when combined with minoxidil and finasteride, significantly improved the clinical efficacy of these drugs for treating mild-to-severe androgenic alopecia compared to drug treatment alone over six months.

In this study, a shampoo and hair tonic containing the botanical extract blend Asacurin100 reduced hair loss and improved scalp health in 35 male participants with androgenetic alopecia, without serious side effects, suggesting potential efficacy that warrants larger trials for confirmation.

This study found that a topical 1.0% sildenafil citrate solution significantly increased vellus and terminal hairs in women with female pattern hair loss without affecting hair thickness, suggesting it may be a promising treatment option.